Retatrutide, from Soma Chems , is attracting increasing attention as a novel method for weight management . This dual-action medication integrates the properties of a GLP-1 receptor agonist and a GIP receptor stimulant, designed to not only promote weight loss but also address associated metabolic factors. Preliminary clinical studies have indicate